+検索条件
-Structure paper
| タイトル | Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigen. |
|---|---|
| ジャーナル・号・ページ | Nat Commun, Vol. 17, Issue 1, Page 1197, Year 2026 |
| 掲載日 | 2026年1月3日 |
著者 | Ryan S McCool / Cory M Acreman / Abigail E Powell / Sofia I Picucci / Daniel J Stieh / Chia-Wei Chou / Jeremy Huynh / Hannah Caruso / Soyoon Park / Jessica O'Rear / Jui-Lin Chen / Brad A Palanski / Patrick O Byrne / Madeline R Sponholtz / Jeongryeol Kim / Julie E Ledgerwood / Payton A-B Weidenbacher / Jason S McLellan / ![]() |
| PubMed 要旨 | Epstein-Barr virus (EBV), the causative agent of mononucleosis, is linked to over 140,000 annual cancer-related deaths globally and increases the risk of multiple sclerosis by up to 32-fold. As a ...Epstein-Barr virus (EBV), the causative agent of mononucleosis, is linked to over 140,000 annual cancer-related deaths globally and increases the risk of multiple sclerosis by up to 32-fold. As a herpesvirus, EBV establishes lifelong infection, and over 90% of U.S. adults are EBV-seropositive. Despite its significant disease burden, no approved EBV vaccines or therapeutics exist. Among EBV envelope glycoproteins, the fusion protein (gB) is strictly required for epithelial and B cell infection. Here, using a combination of AlphaFold-guided modeling, rational design, and ThermoMPNN-informed optimization, we engineer a stabilized prefusion gB variant, C3-GT. This construct incorporates two inter-protomeric disulfide bonds and three cavity-filling substitutions, resulting in a melting temperature of 54 °C. Cryo-EM analysis of this construct reveals the prefusion structure of EBV gB, providing insights into the structural transitions required to adopt the postfusion conformation. Murine immunizations and depletion studies with human sera suggest a trend toward improved functional immunogenicity of C3-GT compared to postfusion gB. Collectively, these studies define engineering principles to stabilize class III fusion proteins, provide reagents to interrogate the human antibody response to EBV gB, and lay a foundation for further studies to develop EBV gB-based vaccine candidates. |
リンク | Nat Commun / PubMed:41484092 / PubMed Central |
| 手法 | EM (単粒子) |
| 解像度 | 2.9 - 3.1 Å |
| 構造データ | EMDB-70288, PDB-9oal: EMDB-73043, PDB-9yka: |
| 化合物 | ![]() ChemComp-NAG: |
| 由来 |
|
キーワード | VIRAL PROTEIN / fusion protein / engineered protein / stabilized protein / prefusion protein / gB / glycoprotein B / Post-fusion / AMMO2 / fab |
ムービー
コントローラー
構造ビューア
万見文献について



著者
リンク




human gammaherpesvirus 4 (ヘルペスウイルス)
homo sapiens (ヒト)
キーワード